Abstract
Continuous progress has been achieved during recent decades in the therapy of metastasizing malignancies by improving chemotherapeutic strategies and new approaches in radiation therapy. Genetic manipulation of tumor cells and of the tumor fighting immune system is hoped to add significant contributions to curative interventions in disseminated tumors. That we are still far from eradicating death by malignant growth is due ultimately to our limited understanding of the cascade of events resulting in metastasis formation, which until recently was believed to rely on multiple rounds of mutation and selection processes. This implies an individually specific history of each metastatic tumor, which would rule out uniform diagnostic and therapeutic concepts. When it was noted in a rat tumor model that the transfer of cDNA of a single gene, a CD44 variant isoform (CD44v) covering the exons v4–v7, sufficed to initiate metastasis formation of a locally growing tumor, hope was created that a “metastogene” may have been identified. Although the idea of CD44v expression as a unifying concept for tumor progression was not sustained, the discovery of CD44v-initiated metastatic spread allowed a conceptually new hypothesis on tumor progression as a consequence of the reactivation of genetic programs of ontogeny, stem cell differentiation, and/or lymphocyte activation. Since distinct CD44 isoforms play an important role in these processes, unraveling the functions of this family of molecules can indeed provide a cornerstone in the understanding of tumor progression. This article summarizes briefly the present knowledge on known functions of CD44 isoforms with particular focus on parallels between physiological programs and tumor progression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CD44s :
-
CD44 standard isoform
- CD44v :
-
CD44 variant isoforms
- HA :
-
Hyaluronate
References
Jiang WG (1994) In vitro models of cancer invasion and metastasis: recent developments. Eur J Surg Oncol 20:493–499
Mareel MM, VanRoy FM, Bracke ME (1993) How and when do tumor cells metastasize. Crit Rev Oncog 4:559–594
Wright JA, Turley EA, Greenberg AH (1993) Transforming growth factor beta and fibroblast growth factor as promoters of tumorprogression to malignancy. Crit Rev Oncog 4:473–492
Zetter BR (1993) Adhesion molecules in tumor metastasis. Semin Cancer Biol 4:219–229
Dorudi S, Hart IR (1993) Mechanisms underlying invasion and metastasis. Curr Opin Oncol 5:130–135
Lafrenie R, Shaughnessy SG, Orr FW (1992) Cancer cell interactions with injured or activated endothelium. Cancer Metastasis Rev 11:377–388
Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier W (1992) Cell adhesion in invasion and metastasis. Semin Cell Biol 3:169–178
Behrens J (1994) Cadherins as determinants of tissue morphology and suppression of invasion. Acta Anat Basel 149:165–169
Bosman FT (1993) Integrins: cell adhesives and modulators of cell function. Histochem J 25:469–477
Castronovo V (1993) Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 13:1–30
Whalen GF, Sharif SF (1992) Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumors to lymph nodes. Ann Surg 215:166–171
Rusciano D, Burger MM (1992) Why do cancer cells metastasize into particular organs? Bioessays 14:185–194
Dedhar S (1990) Integrins and tumor invasion. Bioessays 12:583–590
Miller FR, Heppner GH (1990) Cellular interactions in metastasis. Cancer Metastasis Rev 9:21–34
Craft PS, Harris AL (1994) Clinical prognostic significance of tumor angiogenesis. Ann Oncol 5:305–311
Weinsat-Saslow D, Steeg PS (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401–407
Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10:302–313
McCormick BA, Zetter BR (1992) Adhesive interactions in angiogenesis and metastasis. Pharmacol Ther 53:239–260
International Symposium (1989) Critical determinant in cancer progression and metastasis. A centennial celebration of Dr Stephen Paget's seed and soil hypothesis. Cancer Metastasis Rev 8:93–197
Jessup JM, Petrick AT, Toth CA, Ford R, Meterissian S, O'Hara CJ, Steele G, Thomas P (1993) Carcinoembryonic antigen: enhancement of liver colonisation through retention of human colorectal carcinoma cells. Br J Cancer 67:464–470
Radinsky R, Fidler IJ (1992) Regulation of tumor cell growth at organ-specific metastases. In Vivo 6:325–331
Fidler IJ (1991) Cancer metastasis. Br Med Bull 47:157–177
Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: Twenty eighth GHA Clowes Memoral Lecture. Cancer Res 50:6130–6138
Schmidt C, Verschueren H, Toussaint-Demylle D, VanDenBerg T, Kraal G, DeBaetselier P (1994) The role of the spleen in the organ-specific metastasis of murine BW 5147 T lymphomas. Clin Exp Metastasis 12:164–174
Johnson RC, Zhu D, Augustin-Voss HG, Pauli BU (1993) Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung metastatic rat breast and prostate carcinoma cells. J Cell Biol 121:1432–1432
Gattoni-Celli S, Byers RH, Calorini L, Ferrone S (1993) Organ-specific metastases in melanoma: experimental animal models. Pigment Cell Res 6:381–384
Radinsky R (1993) Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Metastasis Rev 12:345–361
Nicolson GL (1993) Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12:325–343
Yeatman T, Nicolson GL (1993) Molecular basis of tumor progression: mechanims of organ-specific tumor metastasis. Semin Surg Oncol 9:256–263
McCarthy SA, Kuzu I, Gatter KC, Bicknell R (1991) Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. Trends Pharmacol Sci 12:462–467
Zhu DZ, Cheng CF, Pauli BU (1991) Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc Natl Acad Sci USA 88:9568–9572
Johnson RC, Augustin-Voss HG, Zhu DZ, Pauli BU (1991) Endothelial cell membrane vesicles in the study of organ preference of metastasis. Cancer Res 51:394–399
Pauli BU, Augustin-Voss HG, ElSabban ME, Johnson RC, Hammer DA (1990) Organ preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev 9:175–189
Long L, Nip J, Brodt P (1994) Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res 54:3732–3737
Edelman GM (1983) Cell adhesion molecules. Science 219:450–457
Edelman GM (1986) Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol 2:81–116
Anderson H (1990) Adhesion molecules and animal development. Experientia 46:2–13
Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25
Knudson CB, Knudson W (1993) Hyaluronan binding proteins in development, tissue homeostasis, and disease. FASEB 7:1233–1241
Nathke IS, Hinck LE, Nelson WJ (1993) Epithelial cell adhesion and development of cell surface polarity: possible mechanims for modulation of cadherin function, organization and distribution. J Cell Sci Suppl 17:139–145
Yap UJ (1994) Concepts of adhesion — a review. N Z Dent J 90:91–97
Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425–433
Dustin ML, Springer TA (1981) Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9:27–66
Shimizu Y, Newman W, Tanaka Y, Shaw S (1992) Lymphocyte interactions with endothelial cells. Immunol Today 13:106–112
Vestweber D (1992) Selectins: cell surface lectins which mediate the binding of leukocytes to endothelial cells. Semin Cell Biol 3:211–220
Ratner S (1992) Lymphocyte migration through extracellular matrix. Invasion Metastasis 12:82–100
Clark BR, Gallagher JT, Dexter TM (1992) Cell adhesion in the stromal regulation of haemopoiesis. Baillieres Clin Haematol 5:619–652
Pardi R, Inverardi L, Bender JR Regulatory mechanisms in leukocyte adhesion flexible receptors for sophisticated travelers. Immuol Today 13:224–230
Simmons PJ, Zannettino A, Gronthos S, Leavesley D (1994) Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma 12:353–363
Hemler ME (1990) VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 8:365–400
Lester BR, McCarthy JB (1992) Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev 11:31–44
Evans CW (1992) Cell adhesion and metastasis. Cell Biol Intern Rep 16:1–10
Behrens J (1993) The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 24:175–184
Glinsky GV (1993) Cell adhesion and metastasis: is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Crit Rev Oncol Hematol 14:229–277
Miyasaka M, Toyama-Sorimachi N (1993) Tumor metastasis and adhesion molecules. Gan To Kagaku Ryoho 20:359–362
Giancotti FG, Mainiero F (1994) Integrin-mediated adhesion and signaling in tumorigenesis. Biochem Biophys Acta 1198:47–64
Williams AF, Barclay AN (1988) The immunglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 6:381–405
Rutishauser U, Acheson A, Hall AK, Sunshine J (1988) NCAM as a regulator of cell-cell interactions. Science 240:53–57
Albeda S, Buck CA (1990) Integrins and other cell adhesion molecules. FASEB J 4:2868–2880
Yong K, Khwaja A (1990) Leukocyte cellular adhesion molecules. Blood Rev 4:211–225
Geiger B, Ayalon O (1992) Cadherins. Annu Rev Cell Biol 8:307–332
Postigo AA, Sanchez-Madrid F (1993) Adhesion and homing molecules. Transpl Proc 25:65–69
Tuckwell DS, Weston SA, Humphries MJ (1993) Integrins: a review of their structure and mechanisms of ligand binding. Symp Soc Exp Biol 47:107–136
Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068–2101
Birchmeier W, Behrens J (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochem Biophys Acta 1198:11–26
Hoffman S, Edelman GM (1983) Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule. Proc Natl Acad Sci USA 80:5762–5766
Haynes BF, Liao HX, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347–350
Screaton GR, Bell MV, Bell JI, Jackson DG (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235–12238
Sonneberg A (1993) Integrins and their ligands. Curr Top Microbiol Immunol 184:7–35
Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271–335
Ruoslathi E (1991) Integrins. J Clin Invest 87:1–5
Lasky LA (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964–969
Goridis C, Brunet JF (1992) NCAM: structural diversity, function and regulation of expression. Semin Cell Biol 3:189–197
Humphries MJ, Mould AP, Tuckwell DS (1993) Dynamic aspects of adhesion receptor function — integrins both twist and shout. Bioessays 15:391–397
Juliano RL, Haskill S (1993) Signal transduction from the extracellular matrix. J Cell Biol 120:577–585
Rosales C, Juliano RL (1995) Signal transduction by cell adhesion receptors in leukocytes. J Leukoc Biol 57:189–198
Honn KV, Tang DG (1992) Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 11:353–375
Hughes EN, Colombatti A, August JT (1981) Murine cell surface glycoproteins. J Biol Chem 256:1014–1021
Jalkanen S, Bargatze RF, de losToyos J, Butcher EC (1986) A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16:1195–1202
Omary MB, Trowbridge IS, Letarte M, Kagnoff MF, Isacke CM (1988) Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 27:460–464
Goldstein LA, Zhou DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC (1989) A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1063–1072
Kansas GS, Wood GS, Daily MO (1989) A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man. J Immunol 142:3050–3057
Zhou DFH, Ding JF, Picker LF, Bargatze RF, Butcher EC, Goeddel DV (1989) Molecular cloning and expression of Pgp-1 — the mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol 143:3390–3395
Quackenbush EJ, Vera S, Greaves A, Letarte M (1990) Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and P85 glycoprotein. Mol Immunol 27:947–955
Lokeshwar VB, Bourguignon LYW (1991) Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-l/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem 266:17983–17989
Camp RL, Kraus TA, Pure E (1991) Variations in the cytoskeletal interaction and post-translational modification of the CD44 homing receptor in macrophages. J Cell Biol 115:1283–1292
Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St. John T (1989) Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci USA 86:4659–4663
Wolffe EJ, Gause WC, Pelfrey CM, Holland SM, Steinberg AD, August JT (1990) The cDNA sequence of mouse Pgp-1 and homolgy to human CD44 cell surface antigen and proteglycan core/link proteins. J Biol Chem 265:341–347
Bosworth BT, StJohn T, Gallatin WM, Harp JA (1991) Sequence of the bovine CD44 cDNA: comparison with human and mouse sequences. Mol Immunol 28:1131–1135
Goldstein LA, Butcher EC (1990) Identification of mRNA that encodes an alternative form of H-CAM (CD44) in lymphoid and nonlymphoid tissues. Immunogenetics 32:389–397
Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13–24
Jackson DG, Buckley J, Bell JI (1992) Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267:4732–4739
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160–12164
Tölg C, Hofmann M, Herrlich P, Ponta H (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225–1229
Cooper DL, Dougherty G, Harn HJ, Jackson S, Baptist EW, Byers J, Datta A, Philips G, Isola NR (1992) The complex CD44 transcriptional unit: alternative splicing of three internal exons generates the epithelial form of CD44. Biochem Biophys Res Commun 182:569–578
Brown TA, Bouchard T, St John T, Wayner E, Carter WG (1991) Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207–221
Haggerty JG, Bretton RH, Milstone LM (1992) Identification and characterization of a cell surface proteoglycan on keratinocytes. J Invest Dermatol 99:374–380
Isola NR, Harn HJ, Cooper DL (1991) Screening recombinant DNA libraries: a rapid and efficient method for isolating cDNA clones utilizing the PCR. Biotechniques 11:580–582
Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292–5297
Tanabe KK, Ellis LM, Saya H (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725–726
Miyake K, Underbill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69–75
Miyake K, Kincade PW (1990) A new adhesion mechanism involving hyaluronate and CD44. Curr Top Microbiol Immunol 166:87–90
Aruffo A, Stamenkovic I, Melnick M, Underbill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313
Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C (1990) The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111:2765–2774
Underbill C (1992) CD44: the hyaluronate receptor. J Cell Sci 103:293–298
Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257–264
Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257–264
Yang B, Yang BL, Savani RC, Turley EA (1994) Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13:286–296
Neame SJ, Isacke CM (1993) The cytoplasmic tail of CD44 is required for basolateral localization in ephitelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts. J Cell Biol 121:1299–1310
He Q, Lesley J, Hyman R, Ishihara K, Kincade PW (1992) Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 119:1711–1719
Lesley J, Kincade PW, Hyman R (1993) Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol 23:1902–1909
Lesley J, Hyman R (1992) CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719–2723
Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817–825
Lokeshwar VB, Fregien N, Bourguignon LY (1994) Ankyrinbinding domain of CD44(Gp85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 126:1099–1109
Ishii S, Ford R, Thomas P, Nachman A, Steele G Jr, Jessup JM (1993) CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg Oncol 2:255–264
Toyama-Sorimachi N, Miyasaka M (1994) A novel ligand for CD44 is sulfated proteoglycan. Int Immunol 6:655–660
Knudson W, Bartnik E, Knudson GB (1993) Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci USA 90:4003–4007
Neame PJ, Barry FP (1993) The link proteins. Experientia 49:393–402
Bourguignon LY, Lokeshwar VB, He H, Chen X, Bourguignon GJ (1992) A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12:4464–4471
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391–401
Wirth K, Arch R, Somasundaram C, Hofmann M, Weber B, Herrlich P, Matzku S, Zöller M (1993) Expression of CD44 isoforms carrying metastasis-associated sequences in newborn and adult rats. Eur J Cancer 29A:1172–1177
Terpe HJ, Stark H, Prehm P, Günthert U (1994) CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry 101:79–89
Kennel SJ, Lankford TK, Foote LJ, Shinpock SG, Stringer C (1993) CD44 expression on murine tissues. J Cell Sci 104:373–382
Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ (1994) CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol 6:49–59
Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54:4539–4546
Günthert U (1993) CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47–73
Hardingham TE, Fasang AJ (1992) Proteoglycans: many forms and many functions. FASEB J 6:861–870
Matzku S, Komitowski D, Miltenberger M, Zöller M (1983) Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metast 3:109–123
Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöller M (1990) Metastatic tumour growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46:919–927
Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443–455
Matzku S, Wenzel A, Liu S, Zöller M (1989) Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 49:1294–1299
Zöller M (1995) CD44 variant expression, lymphocyte homing and lymphogenic metastasis. In: Siess W, Lorenz R, Weber PC (eds) Adhesion molecules and cell signalling: biology and clinical applications, vol 1. Raven Press, New York, pp 201–218
Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le-Pendu J (1994) H blood group antigen carried by CD44v modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54:6275–6281
Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53:1262–1268
Tarin D, Matsumura Y (1993) Deranged activity of the CD44 gene and other loci as bio-markers for progression to metastatic malignancy. J Cell Biochem Suppl 17G: 173–85
Tarin D, Matsumura Y (1993) Deranged CD44 gene activity in malignancy. J Pathol 171:249–250
Thomas L (1993) CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination Bull Cancer Paris 80:833–844
Koopman G, Griffin AW, Ponta H, Herrlich P, Berg van den F, Manten-Horst E, Pals ST (1993) CD44 splice variants; expression on lymphocytes and in neoplasia. Res Immunol 144:750–754
Herrlich P, Zöller M, Pals ST, Ponta H (1993) CD44 splice variants: metastases meet lymphocytes. Immunol Today 14:395–399
Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, Harris AL, Simmons D, Fawcett J (1993) CD44 and cancer screening. Lancet 342:548–549
Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D (1994) CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 54:4238–4242
Combaret V, Lasset C, Bouvier R, Frappaz D, Thiesse P, Rebillard AC, Philip T, Favrot MC (1995) Expression de CD44: un nouveau facteur prognostique pour le neuroblastome. Bull Cancer 82:131–136
Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA (1994) Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer Suppl 8:110–115
Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431–442
Penneys NS, Kaiser M (1993) Cylindroma expresses immunohistochemical markers linking it to eccrine coil. J Cutan Pathol 20:40–43
Liu AY (1994) Expression of CD44 in prostate cancer cells. Cancer Letters 76:63–69
Knudson W, Bartnik E, Knudson GB (1993) Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci USA 90:4003–4007
Kaufmann M, Heider KH, Sinn HP, vonMinckwitz G, Ponta H, Herrlich P (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345:615–619
Iida N, Bourguignon YW (1995) New CD44 splice variants associated with human breast cancers. J Cell Physiol 162:127–133
Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v expression, a new prognostic factor in human breast cancer. Int J Cancer 60:471–477
Matsumura Y, Hanbury D, Smith J, Tarin D (1994) Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 308:619–624
Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA (1993) Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82:3539–3547
Koopman G, Heider KH, Horst E, Adolf GR, Berg van den F, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897–904
Terpe A, Franke F, Stark H, Gustmann C, Mackay C, Marston W, Günthert U (1993) Occurrence of CD44 and its isoforms under orthological and pathological conditions. Verh Dtsch Ges Pathol 77:276–281
Harn, HJ, Lee HS, Homing LI, Lee WH, Ding JH (1994) Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumor cell lines. Biochem Mol Biol Int 33:743–749
Harn HJ, Ho LI, Yu CP, Wang MW, Lee HS, Lin JJ, Lee WH, Isola NR, Cooper DL (1994) The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int 32:233–238
Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL (1994) Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun 200:1015–1022
Wielenga VJM, Heider KH, Offerhaus JA, Adolf GR, Berg van den FM, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754–4756
Heider KH, Hofman M, Horst E, Berg van den F, Ponta H, Herrlich P, Pals ST (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227–233
Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Colorectal cancer prognosis and expression of exon v6 containing CD44 proteins. Lancet 344:1470–1472
Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm AD, Begent RH (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29A: 1995–2002
Kim JC, Ishii S, Ford R, Thomas P, Steele G Jr, Jessup JM (1993) Epitopes for homotypic binding of human carcinoembryonic antigen also participate in adhesion to extracellular matrix proteins. Proc Am Assoc Cancer Res 34:197
Koretz K, Möller P, Lehnen T, Hinz U, Otto HF, Herfarth C (1995) Effect of CD44v6 on survival in colorectal carcinoma. Lancet 345:327–328
Dall P, Hekele A, vonMinckwitz G, Kaufmann M, Ponta H, Herrlich P (1994) Surface protein expression and messenger RNA splicing analysis of CD44 uterine cervical epithelium. Cancer Res 54:3337–3341
Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H (1993) Different expression of CD44 splice variants in intestinal and diffuse type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197–4203
Yokozaki H, Tahara E (1994) Metastasis related genes. Gan To Kagaku Ryoho 21:2541–2548
Guo YJ, Liu G, Wang X, Jin D, Wu M, Ma J, Sy MS (1994) Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 54:422–426
Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019–1022
Harn HJ, Homing LI, Chang JY, Wu CW, Jiang SY, Lee HS, Lee WH (1995) Differential expression of the human metastasis adhesion molecule CD44v in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer 75:1065–1071
Herrlich P, Rudy W, Hofmann M, Arch R, Zöller M, Zawadski V, Tölg C, Hekele A, Koopman G, Pals S, Heider KH, Sleeman J, Ponta H (1993) CD44 and splice variants of CD44 in normal differentiation and tumour progression. In: Hemler ME, Mihich E (eds) Cell adhesion molecules. Plenum Press, New York, pp 265–288
Pals ST, Koopman G, Heider KH, Giffien A, Adolf GR, Berg van den F, Ponta H, Herrlich P, Horst E (1993) CD44 splice variants: expression during lymphocyte activation and tumor progression. Behring Inst Mitt Aug(92):273–277
Wheatley SC, Isacke CM, Crossley PH (1993) Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119:295–306
Sretavan DW, Feng L, Pure E, Reichardt LF (1994) Embryonic neurons of the developing optic chiasm express L1 and CD44 cell surface molecules with opposing effects on retinal axon growth. Neuron 12:957–975
Fenderson BA, Stamenkovic I, Aruffo A (1993) Localization of hyaluronan in mouse embryos during implantation, gastrulation and organogenesis. Differentiation 54:85–98
Culty M, Nguyen HA, Underhill CB (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116:1055–1062
Sampson PM, Rochester CL, Freundlich B, Elias JA (1992) Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production, evidence for cytokine-regulated hyaluronan (hyaluronic acid) degadation and human lung fibroblast-derived hyaluronidase. J Clin Invest 90:1492–1503
Hua Q, Knudson CB, Knudson W (1993) Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 106:365–375
Underhill C, Nguyen HA, Shizari M, Culty M (1993) CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 155:324–336
Edwards JC, Wilkinson LS, Jones HM, Soothill P, Henderson KJ, Worrall JG, Pitsillides AA (1994) The formation of human synovial joint cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion. J Anat 185:355–367
Underhill CB (1993) Hyaluronan is inversely correlated with the expression of CD44 in the derman condensation of the embryonic hair follicle. J Invest Dermatol 101:820–826
Shimizu Y, Shaw S (1991) Lymphocyte interactions with extracellular matrix. FASEB J 5:2292–2299
Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 141:1615–1623
Berg EL, Goldstein LA, Jutila MA, Nakache M, Picker LP, Streeter PR, Wu NW, Zhou D, Butcher EC (1989) Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 108:5–518
Gallatin WM, Wayner EA, Hoffman PA, St. John T, Butcher EC, Carter WG (1989) Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci USA 86:4654–4658
Picker LJ, Nakache M, Butcher EC (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927–937
Miyake K, Underhill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69–75
Scheeren RA, Koopman G, Baan van der S, Mejer CJ, Pals ST (1991) Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes. Eur J Immunol 21:1101–1105
Morimoto K, Robin E, LeBousse Kerdiles MC, Li Y, Clay D, Jasmin C, Smadja-Joffe F (1994) CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood 83:657–662
Verfaillie CM, Benis A, Lida J, McGlave PB, McCarthy JB (1994) Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84:1802–1811
Degrassi A, Hubert DM, Rudikoff S, Anderson AO, Potter M, Coon HG (1993) In vitro culture of primary plasmocytomas requires stromal cell feeder layers. Proc Natl Acad Sci USA 90:2060–2064
Munzig E, Eckert K, Harrach T, Graf H, Maurer HR (1994) Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett 351:215–218
Toyama-Sorimachi N, Miyake K, Miyasaka M (1993) Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+-, Mg2+-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur J Immunol 23:439–446
Oppenheimer Marks N, Davis LS, Lipsky PE (1990) Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol 145:140–148
Wu L, Kincade PW, Shortman K (1993) The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett 38:69–75
Guo YJ, Lin SC, Wang JH, Bigby M, Sy MS (1994) Palmitoylation of CD44 interferes with CD3-mediated signalling in human T lymphocytes. Int Immunol 6:213–221
Guo YJ, Wong JH, Lin SC, Aruffo A, Stamenkovic I, Sy MS (1994) Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin molecules. Cell Immunol 154:202–218
Frogner FJ, O'Neill HC (1992) Lymphocyte recirculation: the need for site-specific receptors to dictate T lymphocyte localization into different tisue sites. Scand J Immunol 35:627–632
Camp RL, Scheynius A, Johansson C, Pure E (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178:497–507
Bruynzeel I, Koopman G, Raaij van der LM, Pals ST, Willemze R (1993) CD44 antibody stimulates adhesion of peripheral blood T cells to keratinocytes through the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Invest Dermatol 100:424–428
O'Sullivan NL, Skandera CA, Chin YH, Montgomery PC (1994) In vitro adhesive interactions between rat lymphocytes and lacrimal gland acinar epithelium. Phenotype of adherent lymphocytes and involvement of adhesion molecules. J Immunol 152:1684–1692
Haegel H, Tolg C, Hofmann M, Ceredig R (1993) Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 122:1067–1077
John St.T, Meyer J, Idzerda R, Gallatin WM (1990) Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:45–52
Belitsos PC, Hildreth JEK, August JT (1990) Homotypic cell aggregation induced by anti-CD44 (Pgp-1) monoclonal antibodies and related to CD44 (Pgp-1) expression. J Immunol 144:1661–1670
Rosenman SJ, Ganji AA, Tedder TF, Gallatin WM (1993) Syncapping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leukoc Biol 53:1–10
Koshiishi I, Shizari M, Underbill CB (1994) CD44 can mediate the adhesion of platelets to hyaluronan. Blood 84:390–396
East JA, Hart IR (1993) CD44 and its role in tumour progression and metastasis. Eur J Cancer 14:1921–1922
Matsumara Y, Tarin D (1992) Significance of CD44 gene product for cancer diagnosis and disease evaluation. Lancet 340:1053–1058
Birchmeier W, Behrens J, Weidner KM, Frixen UH, Schipper J (1991) Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol 3:832–840
Grossi CE, Zarcone D, Tenca C, DeRossi G, Mandelli F (1992) Expression of adhesion molecules in lymphoproliferative disorders. Leukemia 6 [Suppl 4]:35–37
Roos E (1991) Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev 10:33–48
Csanaky G, Kalasz V, Kelenyi G, Losonczy H, Baliko Z, Toth A (1993) Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia. I. Application of the HEV-binding assay to a clinical series. Med Oncol Tumor Pharmacother 10:125–130
Barker HF, Ball J, Drew M, Hamilton MS, Franklin IM (1992) The role of adhesion molecules in multiple myeloma. Leuk Lymphoma 8:189–196
Walter J, Wolf J, Pawlita M, Schirrmacher V, Moldenhauer G, Möller P (1991) Invasive metastatic growth of lymphoblastoid B cells in immunodeficient SCID mice. Verb Dtsch Ges Pathol 75:224–228
Horst E, Meijer CJ, Duijvestijn AM, Hartwig N, Van derHarten HJ, Pals ST (1990) The ontogeny of human lymphocyte recirculation: High endothelial cell antigen (HECA-452) and CD44 homing receptor expression in the development of the immune system. Eur J Immunol 20:1483–1489
Horst E, Meijer CJ, Radaskiewicz T, Dongen van JJ, Pieters R, Figdor CG, Hooftman A, Pals ST (1990) Expression of the human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 4:383–389
Jalkanen S, Jonsuu H, Soderstrom Ko, Klemi P (1991) Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 87:1835–1840
Gjerset RA, Arya J, Volkman S, Haas M (1992) Association of induction of a fully tumorigenic phenotype in murine radiation-induced T-lymphoma cells with loss of differentiation antigens, gain of CD44, and alterations in p53 protein levels. Mol Carcinog 5:190–198
Hawley RG, Wang MH, Fong AZ, Hawley TS (1993) Association between ICAM-1 expression and metastatic capacity of murine B cell hybridomas. Clin Exp Metastasis 11:213–226
Guo Y, Ma J, Wang J, Che, X, Narula J, Bigby M, Wu M, Sy M-S (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54:1561–1565
Thomas L, Etoh T, Stamenkovic I, Mihm MC Jr, Byers HR (1993) Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 100:115–120
Dorudi S, Hart IR (1993) Mechanisms underlying invasion and metastasis. Curr Opin Oncol 5:130–135
Faasen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy J (1992) A cell surface chondroitin sulfate proteoglycan, immunological related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521–531
Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB (1993) Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci 105:501–511
Washington K, Gottfried MR, Telen MJ (1994) Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 25:1043–1049
Asplund T, Heldin P (1994) Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res 15:4516–4523
Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S (1993) Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143:867–874
Merzak A, Koocheckpour S, Pilkington GJ (1994) CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54:3988–3992
Kuppner MC, VanMeir E, Gauthier T, Hamou MF, DeTribolet N (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50:572–577
Teyssier JR, Couillin P, Benard J, Ravisse N, Ulrich E, Cornillet P (1992) A multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant. Cancer Genet Cytogenet 60:14–19
Lesley J, Howes N, Perschl A, Hyman R (1994) Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 180:383–387
Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N (1995) Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673–685
Yanagishita M, Hascall VC (1992) Cell surface heparan sulfate proteoglycans J Biol Chem 267:9451–9454
Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A (1995) CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687–698
Kobayashi M, Imamura M, Uede T, Sakurada K, Maeda S, Iwasaki H, Tsuda Y, Musashi M, Miyazaki T (1994) Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages. Stem Cells 12:316–321
Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW (1990) Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 171:477–488
Kincade PW (1991) Molecular interactions between stromal cells and B lymphocyte precursors. Semin Immunol 3:379–390
Kincade PW (1992) Cell interaction molecules and cytokines which participate in B lymphopoiesis. Baillieres Clin Haematol 5:575–598
Kincade, PW, He Q, Ishihara K, Miyake K, Lesley J, Hyman R (1993) CD44 and other cell interaction molecules contributing to B lymphopoiesis. Curr Top Microbiol Immunol 184:215–222
Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC (1990) Hematopoietic progenitor cell expression of the H-Cam (CD44) homing-associated adhesion molecule. Blood 75:589–595
Sy MS, Guo YJ, Stamenkovic I (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859–866
Sy MS, Guo YJ, Stamenkovic I (1992) Inhibition of tumor growth in vivo with a soluble CD44 immunoglobulin fusion protein. J Exp Med 176:623–627
Shimizu Y, Seventer van GA, Siraganian R, Wahl L, Shaw S (1989) Dual role of the CD44 molecule in T-cell adhesion and activation. J Immunol 143:2457–2463
Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A (1989) CD44 contributes to T cell activation. J Immunol 143:798–801
Denning SM, Le PT, Singer KH, Haynes BF (1990) Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144:7–15
Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, Aune TM (1991) Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147:2493–2499
Conrad P, Rothman BL, Kelley KA, Blue ML (1992) Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 149:1833–1839
Hale LP, Haynes BF (1992) Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 149:3809–3816
Pierres A, Lipcey C, Mawas C, Olive D (1992) A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 22:413–417
Krakauer T (1994) Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production. Immunol Lett 39:121–125
Seth A, Gote L, Nagarkatti M, Nagarkatti PS (1991) T-cellreceptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90-MEL-14. Proc Natl Acad Sci USA 88:7877–7881
Sconocchia G, Titus JA, Segal DM (1994) CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol 153:5473–5481
Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A (1994) Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 an activated T cells. J Immunol 153:21–31
Geppert TD, Lipsky PE (1991) Association of various T cell surface molecules with the cytoskeleton. Effect of cross-linking and activation. J Immunol 146:3298–3305
Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J (1993) The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257–268
Koopman G, Kooyk van Y, deGraaff M, Meyer CJ, Figdor CG, Pals ST (1990) Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 145:3589–3593
Galandrini R, Albi N, Tripodi G, Zarcone D, Terenzi A, Moretta A, Grossi CE., Velardi A (1993) Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150:4225–4335
Funaro A, Spagnoli GC, Momo M, Knapp W, Malavasi F (1994) Stimulation of T cells via CD44 requires LFA-1 interactions and IL-2 production. Hum Immunol 40:267–278
Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682–685
Webb DS, Shimizu Y, Seventer van GA, Shaw S, Gerrard TL (1990) LFA-3, CD44, and CD45: physiological triggers of human monocyte TNF and IL-1 release. Science 249: 1295–1297
Gruber MF, Webb DSA, Gerrard TL (1992) Stimulation of human monocytes via CD45, CD44 and LFA-3 triggers macrophage-colony-stimulating factor production: synergism with lipopolysaccharide and IL-1β. J Immunol 148:1113–1118
Chong ASF, Boussy IA, Graf LH, Scuder P (1992) Stimulation of IFN-γ, TNF-α and TNF-β secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44 and CD45 molecules. Cell Immunol 144:69–79
Noble PW, Lake FR, Henson PM, Riches DW (1993) Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91:2368–2377
Chong AS, Jiang XL, Scuderi P, Lamas M, Graf LH Jr (1994) ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate Interferon gamma production in interleukin-2-activated T cells. Cancer Immunol Immunother 39:127–34
Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS (1993) Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol 152:186–199
Zembala M, Siedlar M, Ruggiero I, Wieckiewicz J, Mytar B, Matteoi M, Colizzi V (1994) The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56:269–274
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zöller, M. CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 73, 425–438 (1995). https://doi.org/10.1007/BF00202261
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202261